TRACI HARTSFIELD: Open Payments
NPI 1407986540 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 42 payments from 11 companies in 2025. Trend: 2023 $736 · 2024 $1,025 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $198 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $116 |
| Edwards Lifesciences Corporation | 3 | $95 |
| Amgen Inc. | 5 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $83 |
| Esperion Therapeutics, Inc. | 4 | $80 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| PFIZER INC. | 2 | $52 |
| Boston Scientific Corporation | 1 | $40 |
| GlaxoSmithKline, LLC. | 2 | $38 |
Products named: LEQVIO, Kerendia, REPATHA, JARDIANCE, NEXLETOL, VERQUVO, SAPIEN 3 Ultra RESILIA, BodyGuardian.
Industry payments across GA — which companies pay providers there.
